MeSH term
Frequency | Condition_Probility | Chromosomes, Human, Pair 18/*genetics | 2 | 2.0 |
Female | 10 | 0.0 |
Gene Expression | 2 | 0.0 |
Humans | 28 | 0.0 |
Lymphoma, Mucosa-Associated Lymphoid Tissue/*genetics/metabolism | 2 | 100.0 |
Male | 12 | 0.0 |
Neoplasm Proteins/genetics/metabolism | 2 | 1.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction/methods | 2 | 0.0 |
*Translocation, Genetic | 13 | 1.0 |
Adult | 6 | 0.0 |
Aged | 8 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
In Situ Hybridization, Fluorescence | 8 | 0.0 |
Middle Aged | 10 | 0.0 |
Prognosis | 2 | 0.0 |
Chromosome Aberrations | 2 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Chromosomes, Human, Pair 11 | 6 | 1.0 |
Chromosomes, Human, Pair 18 | 7 | 6.0 |
DNA, Complementary/analysis | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
*Adaptor Proteins, Signal Transducing | 7 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Enzyme Activation | 3 | 0.0 |
*Lymphoma, Mucosa-Associated Lymphoid Tissue | 4 | 80.0 |
Molecular Sequence Data | 7 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Blotting, Western | 2 | 0.0 |
Chromosomes, Human, Pair 14 | 3 | 1.0 |
NF-kappa B/*metabolism | 4 | 0.0 |
Neoplasm Proteins/genetics/*metabolism | 2 | 1.0 |
Precipitin Tests | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Transfection | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 11 | 3 | 0.0 |
*Chromosomes, Human, Pair 18 | 5 | 3.0 |
Cloning, Molecular | 2 | 0.0 |
Lymphoma, Mucosa-Associated Lymphoid Tissue/*genetics | 7 | 46.0 |
Oncogene Proteins, Fusion/*genetics | 3 | 1.0 |
Transcription, Genetic | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Lymphoma, Mucosa-Associated Lymphoid Tissue/*genetics/pathology | 3 | 50.0 |
Translocation, Genetic | 6 | 0.0 |
Lung Neoplasms/genetics/pathology | 2 | 11.0 |
Neoplasm Proteins/*genetics | 8 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Proteins/*genetics | 4 | 0.0 |
Lymphoma/*genetics | 2 | 4.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
RNA, Neoplasm/analysis | 2 | 0.0 |
Contig Mapping | 2 | 1.0 |
Animals | 7 | 0.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
Membrane Proteins/*immunology | 2 | 3.0 |
Mice | 5 | 0.0 |
T-Lymphocytes/*immunology | 2 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
*Neoplasm Proteins | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
NF-kappa B/immunology/*metabolism | 2 | 33.0 |
Cell Division | 2 | 0.0 |
Cytokines/metabolism | 2 | 0.0 |
Receptors, Antigen, B-Cell/metabolism | 2 | 4.0 |
Receptors, Antigen, T-Cell/immunology/*metabolism | 2 | 20.0 |
Chromosomes, Human, Pair 3 | 2 | 1.0 |
Immunoglobulins, Heavy-Chain/*genetics | 2 | 1.0 |
Trisomy | 2 | 1.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
